| Literature DB >> 35939077 |
Zhi-Da Zhang1, Rong-Rong Li1, Jia-You Chen1, Hong-Xin Huang1, Yin-Wei Cheng1,2,3, Li-Yan Xu4,5,6, En-Min Li7.
Abstract
The post-translational modifications (PTMs), which are crucial in the regulation of protein functions, have great potential as biomarkers of cancer status. Fascin (Fascin actin-bundling protein 1, FSCN1), a key protein in the formation of filopodia that is structurally based on actin filaments (F-actin), is significantly associated with tumor invasion and metastasis. Studies have revealed various regulatory mechanisms of human Fascin, including PTMs. Although a number of Fascin PTM sites have been identified, their exact functions and clinical significance are much less explored. This review explores studies on the functions of Fascin and briefly discusses the regulatory mechanisms of Fascin. Next, to review the role of Fascin PTMs in cell biology and their associations with metastatic disease, we discuss the advances in the characterization of Fascin PTMs, including phosphorylation, ubiquitination, sumoylation, and acetylation, and the main regulatory mechanisms are discussed. Fascin PTMs may be potential targets for therapy for metastatic disease.Entities:
Keywords: Actin bundling; Fascin; Filopodia; Post-translational modifications; Tumor metastasis
Year: 2022 PMID: 35939077 DOI: 10.1007/s00726-022-03193-x
Source DB: PubMed Journal: Amino Acids ISSN: 0939-4451 Impact factor: 3.789